Abstract
There is reason to believe that the unfolding revolution in molecular biology and translational research will allow selective targeting of tumor cells, and radically change the way general practitioners and pediatric oncologists treat and follow children with cancer. This article highlights some of the most promising approaches being tested in the field. By learning about the underlying biology, the remaining hurdles, the projected timeline, and the possible impact of new therapies on the practice of pediatric oncology, health care professionals and patients should be better prepared for the future of pediatric oncology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1339-1368 |
| Number of pages | 30 |
| Journal | Pediatric clinics of North America |
| Volume | 49 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1 2002 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Fingerprint Dive into the research topics of 'Emerging cancer-targeted therapies'. Together they form a unique fingerprint.
Cite this
Arceci, R. J., & Cripe, T. P. (2002). Emerging cancer-targeted therapies. Pediatric clinics of North America, 49(6), 1339-1368. https://doi.org/10.1016/S0031-3955(02)00096-2